"Medizinische und therapeutische Abteilungen und Pflege richten sich nach aktuellen Erkenntnissen. Achtung vor dem Leben, ganzheitliche Zuwendung gegenüber Patienten u. Angehörigen prägen unsere Klinik"

During the past decade, Krankenhaus der Barmherzigen Brüder conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 8 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder" #1 sponsor was "University of Ulm" with 7 trials, followed by "Abbott Medical Devices" with 5 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Elixir Medical Corporation" with 4 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus der Barmherzigen Brüder" are "Coronary Artery Disease" (12 trials), "Acute Myeloid Leukemia (AML)" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Aortic Valve Stenosis" (3 trials) and "Coronary Artery Stenosis" (3 trials). Many other conditions were trialed in "Krankenhaus der Barmherzigen Brüder" in a lesser frequency.

Most popular intervention types in "Krankenhaus der Barmherzigen Brüder" are "Drug" (25 trials), "Device" (24 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (5 trials), "Placebo" (5 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus der Barmherzigen Brüder" are 60 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 18 active trials in "Krankenhaus der Barmherzigen Brüder". 1 are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Krankenhaus der Barmherzigen Brüder, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus der Barmherzigen Brüder, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".

Krankenhaus der Barmherzigen Brüder has several departments that took part in Clinical trials: "Krankenhaus der Barmherzigen Brüder Trier; Innere Medizin I, Hämatologie / Internistische Onkologie" - 3 trials, "Diabetologische Schwerpunktpraxis" - 2 trials